China Electrocardiograph (ECG) Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The China Electrocardiograph (ECG) Market Report is Segmented by Product Type (Resting (12-Lead ECG) Systems, Stress ECG Systems, Holter ECG Systems, and ECG Management Software). The Report Offers the Market Size As Value (USD) and Volume (Units) for the Above Segments.

China Electrocardiograph (ECG) Market Size and Share

China Electrocardiograph (ECG) Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Benchmark China Electrocardiograph (ECG) Against Other Healthcare Markets

China Electrocardiograph (ECG) Market Analysis by Mordor Intelligence

The China Electrocardiograph Market size is expected to increase from USD 133.51 million in 2026 to USD 141.24 million in 2027 and reach USD 187.14 million by 2032, growing at a CAGR of 5.79% over 2027-2032.

An electrocardiograph (ECG or EKG) is a medical device used to record the heart's electrical activity. China’s ECG market is gaining traction as healthcare providers place greater emphasis on timely cardiovascular diagnosis and monitoring. The demand for ECG devices is being reinforced by the growing incidence of cardiac disorders, improved access to medical care, and the integration of advanced diagnostic solutions into clinical practice. As healthcare services continue to modernize and preventive care receives greater attention, the adoption of ECG systems is likely to increase steadily throughout the forecast period.

The increasing burden of cardiovascular diseases (CVDs) in China has become a key factor supporting demand for electrocardiography (ECG) devices, as healthcare providers prioritize timely cardiac assessment and continuous patient monitoring. Contributing factors such as population aging, changing lifestyle patterns, and rapid urbanization have heightened the incidence of heart-related conditions, reinforcing the need for effective diagnostic solutions. For example, statistics released by the National Health Commission’s Coronary Heart Disease Intervention Technology Quality Control Center in 2023 showed that reported ST-elevation myocardial infarction (STEMI) cases increased from 163,451 in 2022 to 177,598 in 2023. This rise in acute cardiac events highlights the growing clinical burden of cardiovascular disorders and is contributing to greater adoption of ECG-based diagnostic and monitoring technologies, supporting market expansion across China.

Innovations in ECG technology have significantly enhanced accessibility for healthcare providers and patients, making these tools easier to use. These advancements in devices, which offer improved accuracy, connectivity, and user-friendliness, are directly influencing the market dynamics. For instance, in December 2024, researchers at the University of Science and Technology of China achieved progress in non-contact cardiac activity perception. They utilized the "beat frequency effect," a critical physical phenomenon, to analyze the harmonics of cardiac mechanical activity. Such technological breakthroughs, emphasizing non-contact convenience and high precision, are increasing the adoption of ECG monitoring devices, thereby driving market growth.

The increasing prevalence of cardiac problems, coupled with advancements in ECG device technology, is anticipated to drive market growth over the forecast period. However, the limited availability of trained healthcare personnel capable of accurately interpreting ECG results and operating advanced cardiac diagnostic systems may hinder broader adoption. This challenge is particularly evident in lower-tier healthcare facilities, where resource and expertise gaps can restrict the effective utilization of ECG technologies.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Competitive Landscape

Market Concentration

China Electrocardiograph (ECG) Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

China’s electrocardiograph (ECG) market features a competitive environment shaped by both well-established manufacturers and a growing number of innovative entrants. While a handful of leading companies maintain significant market positions, ongoing product development, technological innovation, and expanding healthcare demand continue to create opportunities for new participants. The presence of vendors offering niche and application-specific ECG solutions further enhances market diversity, fostering an active and continuously evolving competitive landscape. Some of the major players in the market include EDAN Instruments, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., SCHILLER, Lepu Medical Technology(Beijing)Co.,Ltd., among others.

China Electrocardiograph (ECG) Industry Leaders

  1. Lepu Medical Technology(Beijing)Co.,Ltd.

  2. EDAN Instruments, Inc

  3. Nihon Kohden Corporation

  4. Koninklijke Philips N.V.

  5. SCHILLER

  6. *Disclaimer: Major Players sorted in no particular order

China Electrocardiograph (ECG) Market Companies Covered in this Report

  • Lepu Medical
  • Contec Medical Systems
  • EDAN Instruments, Inc.
  • Nihon Kohden
  • Koninklijke Philips
  • Schiller
  • Shanghai MedEco Industry Co.,Ltd.
  • Jiangsu Rooe Medical Technology Co.,Ltd.

Recent Industry Developments in China Electrocardiograph (ECG) Market

  • July 2024: Beijing Winnie Huili Medical Equipment Co., Ltd, a marketing agent for Welch Allyn, Inc., has received approval from the National Medical Products Administration (NMPA) for its Electrocardiograph (ECG) device, registered under Certificate Number 20142075933. This approval highlights the company's role in expanding the availability of advanced ECG devices in the medical equipment market.
  • May 2024: Shenzhen Kaiwoer Electronics Co., Ltd has received approval from the National Medical Products Administration (NMPA) for its Multi-channel ECG machine, registered under Certificate Number 20213070059. This approval positions the company to strengthen its presence in the medical devices market, particularly in the diagnostic equipment segment.

Table of Contents for China Electrocardiograph (ECG) Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry
  • 4.5 PESTLE Analysis
  • 4.6 Industry Trends: By Product Type
    • 4.6.1 Number of End Users
    • 4.6.2 Average Product Usage per End User
    • 4.6.3 Product Replacement Cycle
  • 4.7 Regulatory Framework

5. PRICING ANALYSIS

  • 5.1 Average Selling Prices of ECG Products
  • 5.2 Average Selling Price of Key Players By ECG Products

6. MARKET SEGMENTATION (Market Size by Value in USD and Volume in Units)

  • 6.1 By Product Type
    • 6.1.1 Resting ECG Systems
    • 6.1.2 Stress ECG Systems
    • 6.1.3 Holter ECG Systems
    • 6.1.4 ECG Management Software

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Lepu Medical Technology(Beijing)Co.,Ltd.
    • 7.1.2 Contec Medical Systems Co., Ltd.
    • 7.1.3 EDAN Instruments, Inc.
    • 7.1.4 Nihon Kohden Corporation
    • 7.1.5 Koninklijke Philips N.V.
    • 7.1.6 SCHILLER
    • 7.1.7 Shanghai MedEco Industry Co.,Ltd.
    • 7.1.8 Jiangsu Rooe Medical Technology Co.,Ltd.
  • *List Not Exhaustive
  • 7.2 Company Ranking Analysis: Top 5 Leaders

8. ANALYST RECOMMENDATIONS: EMERGING TRENDS AND OPPORTUNITIES

**Subject to Availability

China Electrocardiograph (ECG) Market Report Scope

As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram. 

The China ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The China electrocardiograph (ECG) market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.

Segmentation Overview

By Product Type
China Electrocardiograph (ECG) Market segmentation breakdown
Resting ECG Systems
Stress ECG Systems
Holter ECG Systems
ECG Management Software
China Electrocardiograph (ECG) Market segmentation breakdown
By Product Type Resting ECG Systems
Stress ECG Systems
Holter ECG Systems
ECG Management Software

Key Questions Answered in the Report

How big is the China Electrocardiograph Market?

The China Electrocardiograph Market size is expected to reach USD 133.51 million in 2026 and grow at a CAGR of 5.79% to reach USD 187.14 million by 2032.

What is the current China Electrocardiograph Market size?

In 2026, the China Electrocardiograph Market size is expected to reach USD 133.51 million.

Who are the key players in China Electrocardiograph Market?

Lepu Medical Technology(Beijing)Co.,Ltd., EDAN Instruments, Inc, Nihon Kohden Corporation, Koninklijke Philips N.V. and SCHILLER are the major companies operating in the China Electrocardiograph Market.

What years does this China Electrocardiograph Market cover, and what was the market size in 2025?

In 2025, the China Electrocardiograph Market size was estimated at USD 126.20 million. The report covers the China Electrocardiograph Market historical market size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the China Electrocardiograph Market size for years: 2026, 2027, 2028, 2029, 2030, 2031, and 2032.

Page last updated on: